Uptake of Subdermal Contraceptive Implants in Alex Ekwueme Federal University Teaching Hospital Abakaliki

Onyema Malachy Chizoba¹, Nwafor Johnbosco Ifunanya^1, , Oliobi Wendy Chinwe¹, Okoye Paschal Chijioke¹, Nweke Assumpta Nnenna¹ and Uche-Nwidagu Bridget Nkiruka¹

¹Department of Obstetrics and Gynaecology, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria

Cite this paper

Onyema Malachy Chizoba, Nwafor Johnbosco Ifunanya, Oliobi Wendy Chinwe, Okoye Paschal Chijioke, Nweke Assumpta Nnenna and Uche-Nwidagu Bridget Nkiruka. Uptake of Subdermal Contraceptive Implants in Alex Ekwueme Federal University Teaching Hospital Abakaliki. American Journal of Public Health Research. 2019; 7(5):167-170. doi: 10.12691/AJPHR-7-5-1

Abstract

Background: Subdermal contraceptive implant is one of the major forms of long acting reversible progestogen-only contraceptives. It is very reliable and its acceptance is on the increase globally. There is a need to evaluate its use among women of reproductive age group in Abakaliki. Aim: To review the uptake and discontinuation of Subdermal contraceptive implants-Jadelle and Implanon at the Alex Ekwueme Federal University Teaching Hospital Abakaliki. Materials and Methods: This was a 3-year retrospective study undertaken between 1^st January 2013 to 31^st December, 2015 which involved 516 study participants. Client characteristics, the reason for implant uptake and reason for discontinuation of contraceptive implants were collected using a specially designed proforma. The statistical analysis was performed using SPSS version 22. Result: The implant acceptance rate over the study period was 50.2%, and it represents the highest contraceptive uptake in the facility. The mean age of the clients was 31.87±4.94 years, while the mean parity was 4.75±2.33. Majority (326/516) 63.2% had Jadelle while the remaining 190 clients (36.8%) had Implanon inserted. Most of the clients were aged between 20 and 34 years, and were multiparous. Majority (61.7%) of the clients got the information from health care personnel, while the media was the least source of contraceptive information. The discontinuation rate for implants in the facility was 20.2%, (16.1% for Jadelle and 4.1% for Implanon). There was no pregnancy recorded among the client during the study period. The commonest reasons given for discontinuation of the contraceptive method was the desire for more pregnancies. Conclusion: Contraceptive implants are the commonest form of contraceptive uptake in our facility. The pearl index was 0% with a high discontinuation rate.

Keywords

contraceptive implants, Jadelle, Implanon, uptake, Abakaliki

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Sharon TC, Anna G. Contraception and sterilization. In: Edmonds DK, editor. Dewhurst’s Text book of Obstetric and Gynaecology. 8th edition. London. Wiley- Blackwell publications; 2012: 495-512.
[2]	Engender health, SEED Assessment Guide for Family Planning Programming. Engender Health, New York. 2011. http://www.engenderhealth.org/pubs/familyplanning/seed-assesment-guide-for-family-planning.php (Accessed 09/03/16).
[3]	Hubacher D, Olano A, Manduku C, Kiarie J. Factors associated with uptake of subdermal contraceptive implants in a young Kenyan population. Contraception. 2011; 84: 413-417.
[4]	Federal Ministry of Health. Nigeria Family Planning Blueprint (Scale-up plan) Federal Government of Nigeria; 2014.
[5]	National Population Commission and ICP international 2014. Nigeria Demographic and Health Survey Abuja, Nigeria and Rockville, Maryland, USA. NPC and ICF international; 2013.
[6]	Irinyenikan TA. Perception of women about implanon as a contraceptive method in Akure Western Nigeria. Br J Med Medical Res. 2016; 12(7): 1-16.
[7]	Reproductive Health Supplies Coalition. Product Brief- caucus on new and Underused Reproductive Health Technologies. http://www.rhsupplies.org/working-groups/caucus-on-new underused -rh-technologies.html.
[8]	WHO. Medical Eligibility Criteria for Contraceptive use. 4thed. Geneva: WHO; 2010. Available from: http://www.who.int/reproductivehealth/publications/family-planning/9789241563888er. (Accessed on 09/03/16).
[9]	Monga A, Dobbs S. Fertility Control, Contraception and Abortion. In: Gynaecology by Ten Teachers. 19th Edition. London. Book Power. 2011; 62-84.
[10]	Madugu NH, Abdul MA, Bawa U, Kolawole B. Uptake of hormonal implant contraceptive in Zaria. Northern Nig Open J of Obstet and Gynaecol. 2015; 5: 268-273.
[11]	Mansour D. Nexplanon R: What Implanon did next. J family planning and reprod Health Care. 2010; 36(4): 187.
[12]	Emuveyan EE. Advances in Contraception. In:Kwawukume EY, Emuveyan EE (Editors). Comprehensive Gynaecology in the Tropics. Accra. Graphic Packaging Limited. 2005; 233-241.
[13]	Grentzer J, McNicholas, Peipert JF. Use of the Etonogestrel-Releasing Contraceptive Implant. Expert Rev Obstet Gynecol. 2013; 8(4): 337-344.
[14]	Mornar S. Chan LN, Mistretta S, Neustadt A, Martins S, Gilliam M. pharmacokinetics of etonogestrel contraceptive implant in obese women. Am. J. Obstet. Gynecol. 2012; 207(2): 110.e 110e.6.
[15]	Xu H, Wade JA, Peipert JF, Zhao Q, Madden T, Seawa GM. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet gynecol. 2012; 120(1), 21-25.
[16]	Egede JO, Onoh RC, Umeora OU, Iyoke CA, Dimejesi IB, Lawani LO. Contraceptive prevalence and preference in a cohort of south-east Nigerian women. Patient preference and adherence. 2015; 9: 707-714.
[17]	Oluwole EO, Kuyimu YA, Goodman OO, Odugbemi BA, Akinyinka MR. Factors influencing the uptake of modern family planning methods among women of reproductive age in a rural community in Lagos state. Inter J Trop Dis and Health. 2016; 11(3): 1-11.
[18]	Umeh A, Abah M. Contraception awareness and practice amongst antenatal attendees in Uyo, Nigeria. Pan Afric Med J. 2011; 10.53. Available @: http://www.panafrican-med-journal.com/content/article/10153/fm.
[19]	Department of Social and Economic Affairs. Charting the progress of populations; contraceptive prevalence. United Nations Population Division. United Nations. 2010. Available @ http://www.un.org./en/development/desa/population/publications.trends/progress-of-population.shtml. (Accessed 22/03/16).
[20]	Ezegwui H, Onoh R, Ikeako L, Onyebuchi A, Umeora A, Umeora O et al. Investigating maternal mortality in a public teaching hospital, Abakaliki, Ebonyi State , Nigeria. Ann med Health Sci Res. 2013; 3(1): 75-80.
[21]	Nwali MI, Ejikeme BN, Agboeze JJ. A 5 year clinical evaluation of subdermal implants among Abakaliki acceptors. J Basic and Clin Reprod Sci. 2016; 5(1): 1-5.
[22]	Abasiattai AM, Utuk NM, Inyang-Etoh EC. Subdermal Contraceptive Implants: Profile of Acceptors in a Tertiary Hospital in Southern Nigeria. Int J Gynecol Obstet Neonatal Care 2014; 1: 9-13.
[23]	Ojule JD, Oranu EO, Enyindah CE. Experience with Implanon in Southern Nigeria J Med Medical Sci 2012; 3(11): 710-714.
[24]	Balogun OR, Olaomo N, Adeniran AS, Fawole AA. Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria. J Med Biomed Sci 2014; 3(1): 1-5.
[25]	Adekunle LV, Olaseha IO, Adeniyi JO. Potential Impact of the Mass Media on Family Planning in an Urban Community in South Western Nigeria. Trop J Obstet Gynaecol 2004; 21: 88-90.
[26]	Power J, French R, Cowan F. Subdermal implantable contraceptive versus other form of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Data Syst Rev 2007; 18(3): CD001326.